The North American neurological disorder drug industry is growing significantly over the forecast period (2020-2026) owing to the rising prevalence of neurological disorders, rising geriatric population, rapid R&D activities by the players in the region. For instance, in May 2019, Allergan Plc announced to share approximately 29 presentations at the 71st Annual American Academy of Neurology (AAN) Meeting regarding neurological disorders and their treatment options.

Further, in December 2019, Ubrelvy was approved by the US FDA. Ubrelvy is a novel drug manufactured by Allergan Plc for the treatment of neurological disorders especially migraine.

Request a Free Sample of our North American Neurological Disorder Drugs Market: https://www.omrglobal.com/request-sample/north-american-neurological-disorder-drugs-market

Besides, some other players that support the growth of the North American neurological disorder drugs market. Players such as Eli Lilly and Co., Merck & Co. Inc., and Allergan Plc., among others are significantly contributing to the market growth. These players are continuously contributing to the growth of the market by adopting several growth strategies in order to curb a large customer base as well as thrive in such a competitive market.

A full Report of North American Neurological Disorder Drugs Market is Available at: https://www.omrglobal.com/industry-reports/north-american-neurological-disorder-drugs-market

Market Coverage

• Market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Disorder Type
• Region Covered- North America
• Competitive Landscape- Eli Lilly and Co., Merck & Co. Inc., Allergan Plc., AstraZeneca Plc, Pfizer Inc., Biogen Inc., and Amgen Inc.

Key questions addressed by the report

• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID-19 forecast
o Most affected segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

North America Neurological Disorder Drugs Market – Segmentation

By Disorder Type

• Alzheimer’s Disease
• Parkinson’s Disease
• Multiple Sclerosis
• Huntington Disease
• Others

North America Neurological Disorder Drugs Market – Countries Covered

• US
• Canada

Company Profiles

• AbbVie Inc.
• Overview
• Abbvie Inc. in North America
• Abbvies Inc. in Neurological Disorder Drugs Landscape
• Recent Developments
• ACADIA Pharmaceuticals Inc.
• ApotexInc.
• Allergan Plc
• Amgen Inc.
• AstraZeneca Plc
• Biogen Inc.
• Boehringer Ingelheim International GmbH
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-neurological-disorder-drugs-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404